Trials / Sponsors / Vaxxinity, Inc.
Vaxxinity, Inc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | A Study to Investigate the Safety, Tolerability, Immunogenicity, and Pharmacodynamics of VXX-401 Administered Hypercholesterolemia | Phase 1 | 2023-03-07 |
| Completed | A Phase 1 Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-313 in Healthy Participants Migraine | Phase 1 | 2022-07-06 |
| Unknown | Platform Trial to Compare Homologous Boost of Authorized COVID-19 Vaccines and Heterologous Boost With UB-612 COVID-19 Vaccines | Phase 3 | 2022-03-16 |
| Withdrawn | A Study to Evaluate the Safety, Immunogenicity, and Efficacy of UB-612 COVID-19 Vaccine Covid-19, SARS-CoV-2, Coronavirus | Phase 2 / Phase 3 | 2021-02-01 |